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Abstract
Background: Energetic and metabolic circuits that orchestrate cell differentiation are largely unknown. Adenylate kinase
(AK) and associated AMP-activated protein kinase (AMPK) constitute a major metabolic signaling axis, yet the role of this
system in guiding differentiation and lineage specification remains undefined.
Methods and Results: Cardiac stem cell differentiation is the earliest event in organogenesis, and a suitable model of
developmental bioenergetics. Molecular profiling of embryonic stem cells during cardiogenesis revealed here a distinct
expression pattern of adenylate kinase and AMPK genes that encode the AK-AMP-AMPK metabolic surveillance axis. Cardiac
differentiation upregulated cytosolic AK1 isoform, doubled AMP-generating adenylate kinase activity, and increased AMP/
ATP ratio. At cell cycle initiation, AK1 translocated into the nucleus and associated with centromeres during energy-
consuming metaphase. Concomitantly, the cardiac AMP-signal receptor AMPKa2 was upregulated and redistributed to the
nuclear compartment as signaling-competent phosphorylated p-AMPKa(Thr172). The cardiogenic growth factor TGF-b
promoted AK1 expression, while knockdown of AK1, AK2 and AK5 activities with siRNA or suppression by hyperglycemia
disrupted cardiogenesis compromising mitochondrial and myofibrillar network formation and contractile performance.
Induction of creatine kinase, the alternate phosphotransfer pathway, compensated for adenylate kinase-dependent
energetic deficits.
Conclusions: Developmental deployment and upregulation of the adenylate kinase/AMPK tandem provides a
nucleocytosolic energetic and metabolic signaling vector integral to execution of stem cell cardiac differentiation.
Targeted redistribution of the adenylate kinase-AMPK circuit associated with cell cycle and asymmetric cell division
uncovers a regulator for cardiogenesis and heart tissue regeneration.
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Introduction
Energetic and metabolic signaling circuits are critical for organ
function from embryonic development, and throughout lifespan
[1,2,3,4,5,6,7,8]. Cardiac specification and differentiation of stem
cells is the earliest event in organogenesis requiring coordinated
organization of the metabolic infrastructure to meet energy
demands of the newly formed heart tissue [9,10,11,12,13,14,15].
Cardiogenic differentiation mandates robust metabolic signaling
and information exchange between mitochondria and cytosolic/
nuclear compartments to ensure developmental programming and
an energetic continuum that sustains the function of nascent
cardiomyocytes [7,16,17,18].
Underlying the transition from low-energy requiring pluripo-
tency into a cardiac phenotype is a switch in energy metabolism,
from anaerobic glycolysis to more efficient mitochondrial oxidative
phosphorylation [9,19,20]. Glycolytic and creatine kinase network
formation provides energetic connectivity between expanding
mitochondrial clusters and ATP-utilization cellular sites [9,17,21].
Despite advances in decoding the dynamics of major ATP produ-
ction and distribution processes during lineage specification,
metabolic signaling circuits responsible for integration of energetic
events with cardiogenic programming remain largely unknown.
Adenylate kinase phosphorelays are recognized facilitators of
metabolic signaling, optimizing intracellular energetic communi-
cation and local ATP supply [7,22,23]. The unique property of
adenylate kinase catalysis to transfer both b- and c-phosphoryls
doubles the energetic potential of the ATP molecule, and provides
a thermodynamically efficient mechanism for high-energy phos-
phoryl transport from mitochondria to myofibrils and the cell
nucleus [7,16,24,25,26,27]. Recent studies indicate that mito-
chondrial adenylate kinase (AK2) is required for unfolded protein
response [28] and that AK2 deficiency compromises embryonic
development and hematopoiesis by interfering with mitochondrial
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responsive adenylate kinase isoform network, coupled with AMP
signaling through AMP-activated kinase (AMPK), provides high-
fidelity surveillance of energy metabolism to sustain the balance of
energy supply and demand [7,22,32]. The metabolic sensor
AMPK appears essential for embryonic development, maintaining
cell polarity and cell cycle progression [18,33,34,35,36], and the
upstream kinase LKB1 is critical for cardiac development, and in
hematopoietic stem cell maintenance and cell division [37,38,
39,40]. However, the contribution of the adenylate kinase/AMPK
tandem in stem cell cardiac differentiation has not been
determined.
Here, we uncovered a developmental deployment and upregu-
lation of the integrated adenylate kinase and AMP-AMPK
signaling system underlying the execution of cardiogenic pro-
gramming during embryonic stem cell differentiation. Nuclear
translocation of adenylate kinase and p-AMPK supported energy-
dependent cell division, and facilitated asymmetric differentiation
leading to cardiac specification. Targeted knockdown of the
adenylate kinase-dependent energetic and AMP signaling cascade
disrupted maturation of mitochondrial networks and myofibrillo-
genesis, precluding formation and function of organized cardiac
beating structures.
Results and Discussion
Restructuring of the adenylate kinase isoform network in
stem cell cardiogenesis
Transcriptional profiling revealed a dynamic regulation of
adenylate kinase genes associated with differentiation of embry-
onic stem cells into cardiomyocytes (Fig. 1A). Compared to the
pluripotent stem cell source, cytosolic AK1 and AK5 isoforms
were upregulated, while mitochondrial AK2 and AK4 and cell
motility-associated AK7 were downregulated in cardiomyocytes
(Figure 1A). Total adenylate kinase activity was doubled, from
0.160.01 mmol/min/mg protein in embryonic stem cells to
Figure 1. Cardiac differentiation is associated with enhancement and restructuring of the adenylate kinase isoform network.
A - Microarray analyses of total mRNA in embryonic stem (ES) cells and derived cardiomyocytes (CM). Adenylate kinase isoform genes are
hierarchically clustered as mRNA copy numbers of CM versus ES transcripts with extent of fold change color-coded (n=3 in each group). B – ES cells
have lower total adenylate kinase activity than derived CM. C – CM have more AK1 transcripts and protein than ES cells. D and E - CM transcribe AK2
less and AK5 more frequently than ES cells but protein levels of both isoforms are approximately equal. F and G - Confocal immunocytochemistry
indicate cytosolic and limited nuclear localization of AK1 (green) in ES cells (nuclear staining with DAPI, blue) and AK1 association with the cell
membrane (G). H – CM have greater AK1 levels concentrated in the nucleus, perinuclear space and along myofibrils. I – In ES cell-derived CM, AK1 is
present in intercellular nanotubular connections and nucleus (inset). J and K - AK2 is found in the cytoplasm both in ES cells and CM; higher levels of
AK2 in CM formed a punctate pattern within the cytoplasm consistent with mitochondrial localization. L and M - The cytoplasmic localization of the
AK5 isoform did vary between ES cells and ES-derived CM; AK5 protein was low in CM. F to M – representative images of n=5–10. All scale bars are
10 mm. * P,0.05.
doi:10.1371/journal.pone.0019300.g001
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(n=3 per group; Figure 1B). Increased expression was ascribed
to marked upregulation of the AK1 isoform as relative AK1
transcript levels doubled with cardiac differentiation, from
1.0460.05 units in stem cells to 2.2360.1 units in cardiomyocytes
(n=3 per group; Fig. 1C left), corroborated by significant increase
of AK1 at protein level (Fig. 1C middle). The integrated density of
AK1 bands, normalized to a-tubulin levels, was 0.07 for stem cells
and 0.40 for cardiomyocytes (Fig. 1C right). Although the AK2
transcript number was lower in cardiomyocytes (0.63) than stem
cells (1.04), AK2 protein levels were stable during differentiation
(1.11 vs. 1.25; Fig. 1D). There were more AK5 transcripts in
cardiomyocytes (1.160.47 vs. 4.0860.18), but protein levels of
AK5 moderately decreased, from 1.26 in stem cells to 0.93 in
cardiomyocytes, relative to a-tubulin (Fig. 1E). The difference in
adenylate kinase isoform transcripts and protein levels indicates
possible involvement of miRNAs in patterning adenylate kinase
isoforms, and regulating cell differentiation [41].
In embryonic stem cells, AK1 was localized in the cytoplasm
associated with cell membrane, with limited presence in the
nuclear compartment where it appeared excluded from the
nucleolus (Fig. 1F and 1G). In stem cell-derived cardiomyocytes,
abundant AK1 was concentrated in the perinuclear space, and
arranged along myofibrils and sarcolemma (Fig. 1H). Membrane
localization of AK1 could be attributed to the AK1b isoform
which supplies energy and delivers metabolic signals to membrane
metabolic sensors [42,43]. Expression of membrane-bound AK1b
is linked to p53-dependent regulation of cell cycle and cell growth
[44]. A greater nuclear presence of AK1 was also characteristic for
stem cell-derived cardiomyocytes (Fig. 1I inset). Furthermore,
AK1 was concentrated within intercellular nanotubular connec-
tions (Fig. 1I) which contribute to cardiomyocyte differentiation
[45]. The majority of AK2 was cytoplasmic, both in stem cells and
cardiomyocytes (Fig. 1J and 1K), with punctate patterning
consistent with mitochondrial localization (Fig. 1K). Such
distribution of adenylate kinase isoforms is coherent with
formation of a continuous phosphotransfer network, mediating
energy transfer and metabolic signaling between cell compart-
ments [7,46,47]. The cytoplasmic localization of the AK5 isoform
did not vary between stem cells and derived cardiomyocytes
(Fig. 1L and 1M). Consistent with Western blots (Fig. 1E),
immunostaining for AK5 was low in cardiomyocytes (Fig. 1M).
These data are in line with increased adenylate kinase activity
demonstrated in postnatal heart development [48] and cell
differentiation, notably through an AK1 upregulation [49]. Thus
to meet energy and metabolic signaling requirements of
developing cardiomyocytes, cardiac differentiation of stem cells
is associated with a restructured adenylate kinase transcriptome
and proteome.
Developmental enhancement and redistribution of AK1
in cardiogenic differentiation
Early stages of differentiation (day 1–2) were marked by the
appearance of AK1 enriched cells, underscoring initial metabolic
rearrangement (Fig. 2A). Progression of cardiac differentiation
correlated with development of a myofibrillar mesh (a-actinin
staining) and redistribution of AK1 from the perinuclear space
(Fig. 2B lower cell) to the myofibrillar compartment and the entire
cell volume (Fig. 2B upper cell). AK1 distributed asymmetrically
between daughter cells according to the degree of differentiation
(Fig. 2B). Asymmetric differentiation is a proposed mechanism for
generation of cell types by unequal inheritance of cell fate
determinants [50]. When daughter cells progressed with synchro-
ny into functional cardiomyocytes, AK1 distributed equally
(Fig. 2C). Maturation of cardiomyocytes was supported by
development of the myofibrillar network with intercalation of
AK1 within myofibrils and distribution through cell compartments
(Fig. 2C and 2D). Capturing cardiomyocytes in mitosis, revealed
AK1 distributed in the nucleus where it associated with
centrosomes and the mitotic spindle in metaphase (Fig. 2E).
Nuclear translocation of AK1 in metaphase would provide energy
support for chromosome disjunction and powering of cell division,
in line with the role for adenylate kinase in motility of cilia and
flagella which have a 9+2 microtubular structure similar to that of
mitotic spindles [51]. In mitotic spindles, adenylate kinase is in
close vicinity of motor proteins, as in flagella, associating with the
dynein complex to provide ‘‘on site’’ ATP fueling [23,51].
Adenylate kinase also supports nucleocytoplasmic exchange of
macromolecules and regulates nucleotide ratios necessary for
DNA and RNA synthesis [16,52]. In non-dividing cells, a limited
presence of AK1 was noted in the nucleus (Fig. 2E left corner), as
well as in nuclei of mature adult and mitotically silent
cardiomyocytes (not shown). AK1 abundance (Fig. 2F, green,
upper) and tight intercalation within the energy-consuming
contractile apparatus (Fig. 2F, red, lower) underscores a growing
energetic role in active cardiomyocytes. Developmental enhance-
ment of AK1 and deployment in myofibrillar, sarcolemmal and
perinuclear/nuclear compartments, as well as targeted redistribu-
tion associated with cell cycle, highlights the dynamics of
energetic/metabolic signaling circuits in stem cell cardiac
differentiation.
Engagement of AMP/AMPK signaling in stem cell cardiac
differentiation
Concomitant to deployment of the AMP generating adenylate
kinase isoform network, cardiac stem cell differentiation was
associated with augmented AMP nucleotide signaling, increased
expression of the AMP-sensor AMPKa2, a major cardiac isoform,
and nuclear redistribution of the activated and signaling competent
p-AMPKa(Thr172). Cardiac differentiation induced significantly
higher ATP levels, which increased from 29.662.5 nmol/mg
protein in stem cells to 38.862.6 nmol/mg protein in derived
cardiomyocytes (p,0.03, n=4–11; Fig. 3A). Total ADP levels
nearly tripled, from 3.260.3 to 9.260.4 nmol/mg protein in stem
cells and cardiomyocytes, respectively (p,0.01, n=4–11). Corre-
spondingly, the ATP:ADP ratio was halved in cardiomyocytes
(4.260.1) compared to stem cells (10.961.9, p=0.01, n=4–11;
Fig. 3B), indicating a higher turnover of adenine nucleotides
induced by cardiac differentiation. Cell-free AMP levels, calculated
from the adenylate kinase equilibrium, were significantly increased
in cardiomyocytes (0.5760.02 nmol/mg protein) compared to
parental stem cells (0.1260.02 nmol/mg protein; Fig. 3A). The
corresponding AMP:ATP ratio, governing the activity of metabolic
sensors such as AMPK, were markedly elevated in derived
cardiomyocytes (0.01560.001) compared to the stem cell source
(0.00560.001, p,0.01, n=4–11). In fact, differentiation of stem
cells intocardiomyocytes was associated withdistinct transcriptional
regulation of AMPK genes (Fig. 3C). The mRNA levels of Prkaa2,
whichencodesthemajorcardiacAMPKa2catalyticsubunit,tripled
from 0.9860.05 units in stem cells to 3.2160.44 units in derived
cardiomyocytes. Conversely, mRNA levels for Prkaa1, encoding the
a1 catalytic subunit of AMPK, were downregulated with cardiac
differentiation (Fig. 3C). Protein levels of AMPKa2, determined by
Western blot, were also more abundant in cardiomyocytes (Fig. 3C
middle). The integrated density of AMPKa2 bands, normalized to
a-tubulin levels, was on average 0.15 for stem cells, and increased to
0.44 for cardiomyocytes (Fig. 3C middle right). Association and
intercalation of AMPKa2 with myofibrils was evident in a-actinin
Adenylate Kinase-AMPK Metabolic Signaling
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phorylated p-AMPKa(Thr172) was not significantly different
between stem cells and cardiomyocytes (Fig. 3C lower), immuno-
cytochemical confocal microscopy revealed a significantly larger
nuclear presence of p-AMPKa(Thr172) in derived cardiomyocytes
(Fig. 3D and E). Co-staining of cardiomyocytes for p-AMP-
Ka(Thr172) and AMPKa2 indicated significant nuclear co-
localization of AMP signaling with p-AMPKa(Thr172) (Fig. 3E).
Within the nucleus, p-AMPKa(Thr172) concentrated in intra-
nuclear zones to form a speckle-like pattern (Fig. 3E insert),
associated with functional activity in the nucleus [53]. In stem cells,
AMPKa2 staining was limited to a punctate cytosolic pattern with
little presence in nuclei (Fig. 4A), and notably p-AMPKa(Thr172)
was absent from stem cell nuclei (Fig. 4A; DAPI co-stain in inset). In
contrast, cardiomyocytes displayed higher AMPKa2 and p-
AMPKa(Thr172) abundance with augmented p-AMPKa(Thr172)
in the nuclearcompartment (Fig.4B). In the cytosol, bothAMPKa2
and p-AMPKa(Thr172) showed higher presence in the perinuclear
space,andalignmentwithmyofibrilsvisualized bya-actininstaining
(Fig. 4B). Myofibrillar positioning of AMPK would facilitate
activation of glycolysis/glycogenolysis for energy supply to con-
tracting sarcomeres, and promote phosphorylation and mechanical
performance of contractile proteins [18,54,55]. Further delineating
AMP-signaling topography, confocal scans revealed uniform
arrangement of AMPKa2 (green) and p-AMPKa(Thr172) (red)
through stem cell clusters (Fig. 4C). The ratio of p-AMPK/AMPK,
an indicator of AMPK activity, was low in stem cells in the 0.10–
0.15 range, and evenly distributed (Fig. 4C lower) indicating
quiescence of the AMP-signaling system. Conversely, scans of
derived cardiomyocytes showed increased p-AMPKa(Thr172) (red)
in the nuclear and perinuclear space (Fig. 4D), implicating a
localized activation of the AMPK signaling cascade. Notably, total
AMPKa2 levels (Fig. 4D green) were not higher in nuclear
compared to perinuclear space, suggesting that p-AMPKa(Thr172)
may have preferential access to nuclear import mechanisms. The
ratio of p-AMPK/AMPK in the cardiomyocyte cytosol was higher
Figure 2. Developmental enhancement and changes in intracellular distribution of adenylate kinase during cardiogenic
differentiation and maturation. A – Confocal immunocytochemistry of AK1 (green) and AK2 (red) enrichment among ES cells at days 1–2 of
differentiation (nuclear staining with DAPI, blue; in the presence of 2.5 ng/mL TGF-b). B – Asymmetrical differentiation and maturation of daughter
CM correlate with development of a myofibrillar mesh (a-actinin staining, red) and distribution of AK1 (AK1 staining, green) from the perinuclear
space to the myofibrillar compartment and throughout the cell. C – CM that mature into functional cardiomyocytes have similar myofibrillar (red) and
AK1 (green) distribution. D - Maturation of cardiomyocytes is supported by development of a myofibrillar network (a-actinin staining, red),
intercalation of AK1 (green) with myofibrils, and cytosolic distribution. E - During metaphase, AK1 (green) redistributed into cell nucleus and
associated with centromeres in contrast to low nuclear AK1 levels in non-dividing cells (red - a-actinin staining). F - High abundance of AK1 (AK1 -
green, a-actinin- red, upper panel) and tight intercalation with myofibrils (AK1 - green, a-actinin - red, lower panel) in mature ES cell-derived CM.
Representative images of n=6–9. All scale bars are 20 mm, except in E, which is 5 mm.
doi:10.1371/journal.pone.0019300.g002
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compartment(Fig. 4Dlower). Thus, cardiac stem cell differentiation
is characterized by marked activation of the AMP-AMPK signaling
cascade manifested by increased AMP/ATP ratio, expression of
AMPKa2, and redistribution of p-AMPKa(Thr172) into the
nucleus. Activation of the AK-AMP-AMPK signaling axis exerts
effects on glucose and lipid metabolism, gene expression, protein
synthesis and mitochondria biogenesis [2,55,56,57]. Nuclear
translocation of AMPK could thus mediate gene expression by
regulating phosphorylation and acetylation of nuclear transport and
transcription factors involved in cardiac differentiation, such as the
central developmental regulator Mef2C [54,58,59,60]. In this
regard, AMPK regulates protein acetylation through altered
NAD
+ levels and NAD
+-dependent type III deacetylase SIRT1
[61], and through phosphorylation of class IIa histone deacetylase
HDAC which adjusts Mef2 transcriptional activity [62]. The
present data supports the notion that localized and regulated AMP/
AMPK signaling contributes to stem cell cardiac differentiation.
Adenylate kinase knockdown disrupts stem cell cardiac
differentiation
Since transcripts of AK1 and AK5 increase with cardiogenesis
and AK2 is the predominant mitochondrial isoform, the AMP-
generating adenylate kinase system was targeted using a
combination of AK1-AK2-AK5 siRNAs. Transfection of embry-
onic stem cells with AK1-AK2-AK5 siRNAs reduced adenylate
kinase activity on average by 40% (n=3) compared to no siRNA
or scrambled siRNA treatment (Fig. 5A). Transfection of
cardiomyocytes, isolated from embryoid bodies, with AK1 siRNA
reduced adenylate kinase activity by 79% (Fig. 5A), indicating the
feasibility to manipulate adenylate kinase isoform levels with
siRNAs in stem cells and derived cardiomyocytes. Western blots
confirmed that protein levels of AK1, AK2 and AK5 isoforms
were diminished on average by 95%, 48% and 27%, respectively,
in stem cells 48 h following siRNA transfection (Fig. 5B).
Untransfected stem cells gave rise to embryoid bodies that
displayed an average daily rate of beating activity increase of
Figure 3. Developmental enhancement of AMP signaling and intracellular distribution of AMPKa2 and the activated form
p-AMPKa(Thr172) during stem cell cardiac differentiation. A - Compared to ES cells, derived CM have significantly higher total cellular ATP,
ADP and free AMP levels. B - The ATP/ADP ratio was lower while the AMP/ATP ratio was markedly increased in CM compared to ES cells. C - mRNA
levels of Prkaa2, the gene encoding the major cardiac AMPKa2 catalytic subunit, increased .3-fold upon cardiac differentiation while mRNA levels for
Prkaa1, encoding the a1 catalytic subunit of AMPK, were down regulated. Protein level of AMPKa2, determined by Western blots (WB) and
normalized to a-tubulin amount, was more abundant in CM. The amount of phosphorylated p-AMPKa(Thr172) was not significantly different
between ES and CM. D - Immunocytochemical confocal microscopy images of AMPKa2 (green) distribution in ES-derived CM and intercalation with
myofibrils (a-actinin, red). E – Co-immunostaining of CM for AMPKa2 and p-AMPKa(Thr172) indicated significant compartmentalization of AMP
signaling with p-AMPKa(Thr172) localized predominantly in nuclei and concentrated in specific nuclear zones (inset). Representative images of
n=5–7. All scale bars are 10 mm.
doi:10.1371/journal.pone.0019300.g003
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siRNA gave rise to embryoid bodies that had an average daily rate
of increase in beating activity of 9.262% (Fig. 5C). In contrast,
AK1-AK2-AK5 siRNA transfected embryoid bodies had a
significantly lower average daily rate of increase in beating activity,
down to 361% (Fig. 5C). By comparing the change in beating
activity from the first detection of beating activity to day 12, the
percent change in beating area formation remained high in
embryoid bodies derived from untransfected stem cells or those
transfected with scrambled siRNA (151.8633.51 and 382.26145.3
respectively), but not in those derived from cells transfected with the
triple AK1-AK2-AK5 siRNAs (43.9622.4) (Fig. 5C right). In fact,
someembryoid bodies withAK1-AK2-AK5 siRNAs did not initiate
beating activity at all; others had significantly delayed beating area
formation with contractions detectable only after 9 days of
development. Thus, knockdown of three major adenylate kinase
isoforms early in stem cell specification compromises subsequent
development of functional cardiac beating areas. To gain
mechanistic insight into causes of functionally deficient cardiac
beating areas, cardiomyocytes were isolated from embryoid bodies
after knockdown of AK1, AK2 and AK5 isoforms. Control stem
cell-derived cardiomyocytes had an organized and expanded
mitochondrial network necessary for energy supply to developing
sarcomeres and excitation-contraction machinery (Fig. 5D left). In
contrast, mitochondrial network formation was disrupted in
cardiomyocytes isolated from AK1/AK2/AK5-knockdown embry-
oid bodies (Fig. 5D right), and appeared immature with perinuclear
mitochondrial clustering and little presence in cytosolic and
sarcolemmal compartments (Fig. 5D left). Image analysis indicated
that the mitochondrial density was lower, on averageby about three
fold, in AK1/AK2/AK5-knockdown cardiomyocytes compared to
untreated controls. Specifically, the MitoTracker Red fluorescence
Figure 4. Confocal distribution scans of AMPKa2 and p-AMPKa(Thr172) in stem cells and derived cardiomyocytes. A - Confocal
images of AMPKa2 (green) and p-AMPKa(Thr172) (red) in ES cells revealed a restricted punctate cytosolic pattern with little presence in nuclei and
nucleolar exclusion; p-AMPKa(Thr172) could not be detected in nucleus. B - ES-derived CM have higher AMPKa2 (green) and p-AMPKa(Thr172) (red)
abundance with characteristic myofibrillar (a-actinin, white) alignment. The p-AMPKa(Thr172) presence in the nucleus was augmented. C - Confocal
distribution scans of ES cells indicate uniform arrangement of AMPKa2 (green) and p-AMPKa(Thr172) (red) through cell clusters (upper panel) with
low p-AMPK/AMPK ratio (lower panel). D - Confocal distribution scans of ES-derived CM indicate increase in phosphorylated p-AMPKa(Thr172) (red) in
nuclear and perinuclear spaces (upper panel). The p-AMPK/AMPK ratio was higher in the CM nucleus compared to cytosol (lower panel).
Representative images and scans of n=4–6. All scale bars are 10 mm.
doi:10.1371/journal.pone.0019300.g004
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arbitrary units (n=5) after siRNA treatment. These data provide
direct evidence that adenylate kinase and associated metabolic
signaling is essential for cardiac programming, in particular with
respect to mitochondrial biogenesis and spatial distribution, both
critical in cardiogenesis [9,63]. Silencing of adenylate kinase
isoforms could interfere with AMPK-PGC-1a signaling in mito-
chondrial biogenesis [57,63]. Indeed, a lower ratio of p-AMPK/
AMPK was detected in the cardiomyocyte nucleus after AK siRNA
treatment,whichdropped fromanaverageof3.0incontrolto1.5in
cardiomyocytes isolated from AK1/AK2/AK5-knockdown embry-
oid bodies. Of note, AK1 knockout mice present no apparent
developmental cardiac defects which could be related to overlap-
ping function and compensation provided by complementary
adenylate kinase isoforms of which eight are currently known
[7,64]. Deletion of AK2, an isoform silenced here, is embryonically
lethal in mice [65] and Drosophila [29] with severe defects in
mitochondrial structure and energetics, and human mutations of
AK2 are associated with developmental defects [30,31]. Thus,
silencing adenylate kinase isoforms and downstream metabolic
signaling interferes with cardiac stem cell programming by
disrupting mitochondrial biogenesis and network formation.
Adenylate kinase siRNA inhibits cardiogenic
development
Embryoid bodies derived from native stem cells were grown in
suspension according to the hanging drop protocol until day 4
when they were allowed to adhere to a gelatin-coated dish. At this
Figure 5. Beating activity and mitochondrial network formation are disturbed by siRNA knockdown of adenylate kinase isoforms.
A – Adenylate kinase activity was reduced when siRNAs targeting AK1, AK2 and AK5 isoforms were transfected into ES cells and ES-derived CM.
B - Western blots after combinatorial adenylate kinase siRNA knockdown in ES cells. C - Untransfected ES cells and those transfected with a scrambled
sequence siRNA were equally efficient at embryoid body generation. Yet, development of beating areas (right) and increase in activity (left) was
stunted by simultaneous knockdown of AK1/AK2/AK5 isoforms. D - Control ES-derived CM developed organized mitochondrial network but CM
derived from AK1/AK2/AK5 siRNA knockdown ES cells had immature and poorly organized mitochondrial networks. Representative data and images
of n=3–5. All scale bars are 10 mm. Star represents statistical significance at P,0.05.
doi:10.1371/journal.pone.0019300.g005
Adenylate Kinase-AMPK Metabolic Signaling
PLoS ONE | www.plosone.org 7 April 2011 | Volume 6 | Issue 4 | e19300point, they were transfected with triple AK1-AK2-AK5 siRNAs
and transfection efficiency estimated from co-transfection with an
EYFP vector. Approximately 40–60% of the cell population was
reverse transfected (green) (Fig. 6A) and found distributed
throughout the embryoid body including regions that eventually
formed beating areas visualized by increased staining with
electrical activity-sensitive RH237 (red) (Fig. 6B). While embryoid
bodies transfected with no siRNA or a scrambled sequence had
normal beating areas with high electrical activity (red) (Fig. 6C),
embryoid bodies transfected with triple siRNA developed sparse
and poorly organized beating areas if at all (Fig. 6D). Presence of
siRNA transfected cells in beating areas were visualized by co-
transfection with EYFP (green) (Fig. 6C and D). As demonstrated
previously [9], due to mitochondrial abundance and electrical
activity cardiac beating areas are visualized by the mitochondrial
probe JC-1 and plasma membrane potential marker RH237
(Fig. 6E and F). Control embryoid bodies had normal beating
areas with high mitochondrial density (Fig. 6E), however AK1-
AK2-AK5 siRNAs transfected embryoid bodies were unable to
form organized cardiac beating areas and displayed low
mitochondrial density (Fig. 6F). Quantification of embryoid body
beating activity revealed that the percentages of beating embryoid
bodies in control, with or without scrambled siRNA, were 7466
and 10065% (n=32), respectively. In contrast, embryoid
treatment with AK1-AK2-AK5 siRNAs reduced beating embry-
oid bodies to 5067%. Direct measurements of contractile activity,
by changes in cell edge position using confocal microscopy,
revealed that beating areas with normal adenylate kinase levels
had regular contractions with peak amplitudes on average of 700
equivalents, while those with decreased adenylate kinase levels
displayed dyssynchronic contractile patterns with peak amplitudes
reduced to 400 equivalents. To determine if anomaly in beating
area formation was due to a phosphotransfer deficit, culture media
were supplemented with creatine to boost a parallel creatine
kinase-catalyzed phosphotransfer pathway [16]. By itself, creatine
treatment did not significantly affect beating activity as 9066% of
Figure 6. Embryoid bodies transfected with adenylate kinase isoform siRNA cocktail inhibited in cardiac development. A – Overlay of
transmission (gray) and EYFP (green) images of embryoid bodies transfected with siRNA cocktail and EYFP vector during days 4–6 estimated
transfection efficiency at ,50%. B - Transfected cells (green) were found in regions that eventually formed beating areas visualized through increased
staining by plasma membrane potential-sensitive RH 237 (red). C and D – Scrambled siRNA did not affect beating areas (C), but the adenylate kinase
siRNA cocktail reduced the number and quality of beating areas (D). Significant presence of siRNA transfected cells in beating areas visualized by co-
transfection with EYFP (green). E and F - Beating areas visualized using mitochondrial probe JC-1 (green) and RH 237 (red) in control (E) and
adenylate kinase siRNA cocktail transfected (F) embryoid bodies. G – Adenylate kinase siRNA cocktail transfection reduced the percentage of beating
embryoid bodies compared to no or scrambled siRNA transfections. Creatine supplementation of media, at time of adenylate kinase knockdown,
rescued beating. H and I – Contractions of control beating areas and those affected by adenylate kinase siRNA transfection (lower). All scale bars are
20 mm. Representative images and data of n=6–8.
doi:10.1371/journal.pone.0019300.g006
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(Fig. 6G). However, creatine supplementation to embryoid bodies
transfected with AK1-AK2-AK5 siRNAs from the time of
adenylate kinase knockdown rescued deficient beating activity,
increasing beating percentage to 104630% (n=33). Therefore,
creatine supplementation, which increases creatine kinase activity
and phosphocreatine levels [16], compensated for energetic
signaling defects associated with reduction of adenylate kinase
isoforms. As creatine increases AMPK activity [66], it is
conceivable that the creatine kinase circuit could compensate
AK deficit through multiple mechanisms affecting both energetic
and metabolic signaling. Although siRNA knockdown of targeted
proteins in mammalian cells suppressed gene expression for less
than a week (and transfection efficiency was about 50%), this was
sufficient to disrupt cardiogenesis and formation of organized
beating areas in embryoid bodies. Since embryonic development is
a strictly ordered and sequential process of a number of integrated
genetic, energetic and signal transduction events, disruption of
metabolic signaling during the initial stages could lead to serious
consequences in later developmental programming and phenotype
maturation [9,67,68]. Also, organized cardiogenesis is supported
by a cellular network involving interactions of different types of
cells, cell movement, intercellular connections and communication
by signaling molecules [9,45]. In this way, disruption of energetic
and metabolic signaling in few cells could lead to aberrant cellular
network behavior [63]. Thus, intact energetic signaling through
the adenylate kinase network is critical in cardiogenesis and
formation of the first organized and functional structure in the
embryoid body – the cardiac beating area.
Modulation of cardiogenesis by hyperglycemia and
adenylate kinase by cardiogenic TGF-b
The effects of high glucose include suppression of adenylate
kinase phosphotransfer flux and AMPK activity [69,70,71]. When
embryoid bodies were grown in media with a high concentration
of glucose (50 mM), cardiogenesis was impeded as evidenced by
blunted beating activity monitored between day 8 to 12 (Fig. 7A).
Compared to control, cardiac beating area formation was deficient
in high glucose embryoid bodies, which demonstrated lower
mitochondrial content (JC1 staining, green) and weaker electrical
activity (RH237 staining, red) (Fig. 7B and C). With high
concentrations of glucose, the intercalation of the mitochondrial
network with myofibrils was lost (Fig. 7D). Mitochondria appeared
fragmented (Fig. 7E) while myofibrillar formation and organiza-
tion, as assessed by MLC2v-GFP expression, became chaotic and
considerably more modest (Fig. 7G), in contrast to parallel
elongated myofibrils which formed regular patterns (Fig. 7F).
Thus, suppression of the AK-AMP-AMPK signaling cascade by
siRNA transfection and hyperglycemia produced similar inhibito-
ry effects on mitochondrial network formation and stem cell
cardiogenesis. These observations are consistent with reports that
hyperglycemic conditions, such as in diabetes, cause mitochondrial
fragmentation [72] and lead to embryonic cardiac malformation
[73]. Based on previous work, whereby high glucose reduces AMP
levels, AK flux and AMPK activity [43,69,70,71], possible
mechanisms for the observed effect of hyperglycemia may include
diminished adenylate kinase flux and related AMPK-PGC-1a
signaling critical in mitochondrial biogenesis [57,63]. Conversely,
to determine whether cardiogenic factors which stimulate stem cell
cardiac differentiation [74] modify the adenylate kinase isoform
network to achieve their priming effects, embryonic stem cells
were treated with TGF-b for two days. Confocal immunocyto-
chemical analysis indicated that AK1 and AK2 signal intensity was
stronger following TGF-b treatment (Fig. 7H). AK1 protein levels
were higher in stem cells treated with TGF-b (0.82560.57 AU)
versus control (0.38960.02 AU) when quantified by Western blot
(Fig. 7I, left), and total adenylate kinase activity was augmented
(0.12660.003 mmol/min/mgprotein)versus control (0.12260.004)
(Fig. 7I, right). These data support the notion that developmental
enhancement of adenylate kinase-mediated energetic signaling is an
essential event in triggering and promoting stem cell cardiac
differentiation and cardiomyocyte maturation.
Our data is in accord with recent studies unveiling the
significance and interplay of energetic and metabolic signaling
circuits in cellular life. Spatial repositioning of cytosolic adenylate
kinase circuit provides energy for cell motility [23] while
mitochondrial adenylate kinase AK2 facilitates hematopoietic cell
differentiation, unfolded protein response, sound transduction in
inner ear and embryonic development [28,29,30,31]. Both AMPK
and the upstream kinase LKB1 appear to be critical for embryonic
development, maintaining stem cell metabolic homeostasis and
supporting cell division [34,35,36,37,39,75]. In particular, AMPK
was found regulated by the ubiquitin proteasome system and
AMPK activation implicated in increased expression of ubiquitin
ligases which regulate cardiac transcription factors [76]. Also, it
was demonstrated that protein kinase Sik1, a member of the
AMPK family, is integral to the genetic network that controls cell
cycle, while its absence in embryonic stem cells delays cardio-
myogenesis [77]. Cardiac-specific deletion of LKB1, an upstream
AMPK kinase, leads to developmental hypertrophy and dysfunc-
tion [40], while ablation of another AMPK kinase TGF-b-
activated kinase-1, TAK1, causes embryo midgestation lethality
[78]. Moreover, signaling through AMPK-family kinases activated
by LKB1 regulates myosin phosphatases and cell adhesion [79],
further implicating metabolic signaling circuits as common
pathways in the etiology of multiple disease states [80].
In summary, this study provides first evidence for the contri-
bution of the adenylate kinase and AK-AMP-AMPK metabolic
signaling axis in embryonic stem cell cardiac differentiation. It
underscores the significance of nucleocytosolic adenylate kinase-
mediated energetic and AMP-AMPK metabolic signaling in
guiding asymmetric cell differentiation, mitochondrial biogenesis,
and myofibrillar network formation, supporting thereby cell cycle
progression during cardiogenesis. Developmental distribution of
adenylate kinase and AMPK isoforms fosters formation of a
continuous phosphotransfer network, mediating energy transfer
and metabolic signaling between cell compartments required for
developmental programming. Suppression of the adenylate kinase-
dependent AMP signaling cascade and metabolic disturbances,
such as hyperglycemia, disrupted maturation of mitochondrial
network and myofibrillogenesis, precluding formation and func-
tion of organized cardiac beating structures. Collectively, these
findings offer a new perspective in the understanding of develop-
mental system bioenergetics and metabolic signaling circuits in
cardiac regenerative biology.
Materials and Methods
Embryonic stem cell differentiation
Murine embryonic stem cells (CGR8) and those expressing
MLC2v-GFP coupled to the cardiac a-actin promoter [81] were
maintained in Glasgow Minimum Essential Medium (BioWhit-
taker-Cambrex) [74,82]. Cells were differentiated in media
containing 20% FBS using a hanging-drop method [9,83]. Where
applicable, media were supplemented with 5 mM creatine,
50 mM glucose or 2.5 ng/mL TGF-b (Sigma-Aldrich). Forming
embryoid bodies were grown in differentiation medium, then
plated. Beating percentages were determined by light microscopy.
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Embryonic stem cells and cardiomyocytes isolated by Percoll
gradient [9,83] were extracted in 150 mM NaCl, 5 mM EDTA,
60 mM Tris-HCl (pH 7.5), 0.2% Triton X-100 and protease
inhibitors (Complete Mini, Roche). Adenylate kinase activity was
measured as described previously [24]. For Western blots, extracts
were separated through 12% Tris-HCl SDS-PAGE, transferred to
a PVDF membrane and probed with antibodies against AK1,
AK2, AK5, a-tubulin, AMPKa2 and pAMPKa (Santa Cruz
Biotechnology).
Metabolic gene profiling
Total RNA isolated from embryonic stem cells or cardiomyo-
cytes was screened using the mouse genome 430 2.0 array
(Affymetrix). Expression profiles were analyzed with the bioinfor-
matics software Genespring GX 7.3 (Agilent Technologies). Gene
lists were quality filtered to remove genes with expression levels
below background, and limited to report genes that changed by
1.5-fold or greater during cardiac differentiation [9,84,85,86].
Adenine nucleotide measurements
Adenine nucleotide concentrations in cellular perchloric acid
extracts were determined by high performance liquid chromatog-
raphy (Hewlett-Packard Series 1100, Agilent Technologies) using a
triethylamine bicarbonate elution buffer (pH 8.8) [24]. Free AMP
was calculated from measured ATP, estimated free ADP, and
adenylate kinase equilibrium constant according to the equation
([AMP]=(1.05x[ADP]
2)/[ATP]) [87]. The metabolically active
Figure 7. Hyperglycemia disrupts mitochondrial network formation and cardiac myofibrilogenesis, while cardiogenic TGF-b
augments adenylate kinase expression. A – Excess glucose (50 mM) stunted beating activity through day 12. B and C - Beating areas visualized
using JC-1 (green) and membrane potential marker RH 237 (red) in control (B) and high glucose grown embryoid bodies (C). D and E – Mitochondrial
distribution in cardiomyocytes from control (D) and glucose-treated embryoid bodies (E) visualized using MitoTracker Red. F and G – Myofibrillar
formation and organization in control CM (F) versus glucose treated CM (G) assessed by cardiac specific MLC2v-GFP expression. H – Differential AK1
and AK2 immunofluorescent signals in control ES cells (upper) and those treated with TGF-b (lower). I – TGF-b treatment increased AK1 protein levels
quantified by Western blot (left) and adenylate kinase activity (right). Scale bars in B, C and H are 20 mm, in D, E, F and G - 10 mm. Representative
images and data of n=3–5.
doi:10.1371/journal.pone.0019300.g007
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accessible to the adenylate kinase reaction.
Transfection with short interfering RNA (siRNA)
AK1, AK2 and AK5 levels were reduced by isoform specific
siRNAs (Ambion Applied Biosystems) transfected using Lipofecta-
mine 2000 (Invitrogen). Briefly, 2 nmol of siRNA were used in
2 mL of growth media with embryonic stem cells at .50%
confluence. Knockdown efficiency was assessed by adenylate
kinase activity and Western blots 48 h later. In embryoid bodies
adenylate kinase levels were reduced by reverse transfections
performed on day 4 of the hanging drop method. Simultaneous
transfection with pEYFP N1 vector (Clontech) was used to assess
transfection efficiency.
Confocal imaging
For imaging plasma and mitochondrial membrane potentials,
cells were incubated for 30 min at 37uC with 1.3 mM RH 237 and/
or 0.5 mM JC-1 (Invitrogen). The organization and assembly of
beating areas in the developing mesoderm were determined using
LSM 510 META Laser Scanning Systems (Carl Zeiss). Contrac-
tions in beating areas were measured as change in cell edge position
using confocal microscopy, and analyzed with the region of interest
function in the software [9]. For mitochondrial network imaging,
cells were incubated with 3 mM MitoTracker Red CMH2XRos
(Invitrogen) for 30 min at room temperature and fixed in 3%
paraformaldehyde [88]. Cells were stained with one or more
primary antibodies including cardiac a-actinin, AK1, AK2, AK5
(Sigma-Aldrich and Santa Cruz Biotechnology), AMPKa2a n dp -
AMPKa(Thr172) (Cell Signaling and Abcam), and corresponding
secondary antibodies (Santa Cruz Biotechnology).
Statistics
Comparisons between groups were performed by two-tailed
Student’s t-tests. Data are presented as mean6SEM; n refers to
sample size. P,0.05 was considered significant.
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